{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:34:34Z","timestamp":1791858874719,"version":"4.3.4"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,7,11]],"date-time":"2014-07-11T00:00:00Z","timestamp":1405036800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s10689-014-9735-2","type":"journal-article","created":{"date-parts":[[2014,7,10]],"date-time":"2014-07-10T04:48:09Z","timestamp":1404967689000},"page":"637-644","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":314,"title":["Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment"],"prefix":"10.1007","volume":"13","author":[{"given":"Fred H.","family":"Menko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eamonn R.","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura S.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay A.","family":"Middelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristiina","family":"Aittom\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Richard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Marston","family":"Linehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,11]]},"reference":[{"key":"9735_CR1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2340\/0001555553409416","volume":"53","author":"WB Reed","year":"1973","unstructured":"Reed WB, Walker R, Horowitz R (1973) Cutaneous leiomyomata with uterine leiomyomata. Acta Derm Venereol 53:409\u2013416","journal-title":"Acta Derm Venereol"},{"key":"9735_CR2","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/hmg\/ddg148","volume":"12","author":"NA Alam","year":"2003","unstructured":"Alam NA, Rowan AJ, Wortham NC et al (2003) Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet 12:1241\u20131252","journal-title":"Hum Mol Genet"},{"key":"9735_CR3","first-page":"199","volume":"141","author":"NA Alam","year":"2005","unstructured":"Alam NA, Barclay E, Rowan AJ et al (2005) Clinical features of multiple cutaneous and uterine leiomyomatosis. An underdiagnosed tumor syndrome. Arch Dermatol 141:199\u2013206","journal-title":"Arch Dermatol"},{"key":"9735_CR4","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/PAS.0b013e31804375b8","volume":"31","author":"MJ Merino","year":"2007","unstructured":"Merino MJ, Torres-Cabala C, Pinto P et al (2007) The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome. Am J Surg Pathol 31:1578\u20131585","journal-title":"Am J Surg Pathol"},{"key":"9735_CR5","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.juro.2007.01.155","volume":"177","author":"RL Grubb III","year":"2007","unstructured":"Grubb RL III, Franks ME, Toro J et al (2007) Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer. J Urol 177:2074\u20132080","journal-title":"J Urol"},{"key":"9735_CR6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1399-0004.2010.01486.x","volume":"79","author":"DL Smit","year":"2011","unstructured":"Smit DL, Mensenkamp AR, Badeloe S et al (2011) Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis. Clin Genet 79:49\u201359","journal-title":"Clin Genet"},{"key":"9735_CR7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10689-011-9428-z","volume":"10","author":"HJ Lehtonen","year":"2011","unstructured":"Lehtonen HJ (2011) Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics. Fam Cancer 10:397\u2013411","journal-title":"Fam Cancer"},{"key":"9735_CR8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","volume":"30","author":"IPM Tomlinson","year":"2002","unstructured":"Tomlinson IPM, Alam NA, Rowan AJ et al (2002) The Multiple Leiomyoma Consortium. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet 30:406\u2013410","journal-title":"Nat Genet"},{"key":"9735_CR9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1086\/376435","volume":"73","author":"JR Toro","year":"2003","unstructured":"Toro JR, Nickerson ML, Wei M-H et al (2003) Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. Am J Hum Genet 73:95\u2013106","journal-title":"Am J Hum Genet"},{"key":"9735_CR10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/path.2932","volume":"225","author":"C Bardella","year":"2011","unstructured":"Bardella C, El-Bahrawy M, Frizzell N et al (2011) Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status. J Pathol 225:4\u201311","journal-title":"J Pathol"},{"key":"9735_CR11","doi-asserted-by":"crossref","unstructured":"Castro-Vega LJ, Buffet A, De Cubas AA et al (2013) Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas. Hum Mol Genet 23:2440\u20132446","DOI":"10.1093\/hmg\/ddt639"},{"key":"9735_CR12","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1097\/PAS.0b013e318299f2d1","volume":"37","author":"JR Srigley","year":"2013","unstructured":"Srigley JR, Delahunt B, Eble JN et al (2013) The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia. Am J Surg Pathol 37:1469\u20131489","journal-title":"Am J Surg Pathol"},{"key":"9735_CR13","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0000000000000163","volume":"38","author":"Y-B Chen","year":"2014","unstructured":"Chen Y-B, Brannon AR, Toubaji A et al (2014) Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer. Recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry. Am J Surg Pathol 38:627\u2013637","journal-title":"Am J Surg Pathol"},{"key":"9735_CR14","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1365-2230.2005.01977.x","volume":"31","author":"GS Chuang","year":"2005","unstructured":"Chuang GS, Martinez-Mir A, Engler DE et al (2005) Multiple cutaneous and uterine leiomyomata resulting from missense mutations in the fumarate hydratase gene. Clin Exp Dermatol 31:118\u2013121","journal-title":"Clin Exp Dermatol"},{"key":"9735_CR15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/jmg.2005.033506","volume":"43","author":"M-H Wei","year":"2006","unstructured":"Wei M-H, Toure O, Glenn GM et al (2006) Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer. J Med Genet 43:18\u201327","journal-title":"J Med Genet"},{"key":"9735_CR16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/jmg.2010.085068","volume":"48","author":"B Gardie","year":"2011","unstructured":"Gardie B, Remenieras A, Kattygnarath D et al (2011) Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma. J Med Genet 48:226\u2013234","journal-title":"J Med Genet"},{"key":"9735_CR17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1365-2230.2004.01675.x","volume":"30","author":"I Chan","year":"2005","unstructured":"Chan I, Wong T, Martinez-Mir A et al (2005) Familial multiple cutaneous and uterine leiomyomas associated with papillary renal cell cancer. Clin Exp Dermatol 30:75\u201378","journal-title":"Clin Exp Dermatol"},{"key":"9735_CR18","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/jmg.2005.036400","volume":"43","author":"HJ Lehtonen","year":"2006","unstructured":"Lehtonen HJ, Kiuru M, Ylisaukko-oja SK et al (2006) Increased risk of cancer in patients with fumarate hydratase germline mutation. J Med Genet 43:523\u2013526","journal-title":"J Med Genet"},{"key":"9735_CR19","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.humpath.2006.10.011","volume":"38","author":"HJ Lehtonen","year":"2007","unstructured":"Lehtonen HJ, Blanco I, Piulats JM et al (2007) Conventional renal cancer in a patient with fumarate hydratase mutation. Hum Pathol 38:793\u2013796","journal-title":"Hum Pathol"},{"key":"9735_CR20","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/ncponc0773","volume":"4","author":"M Al Refae","year":"2007","unstructured":"Al Refae M, Wong N, Patenaude F et al (2007) Hereditary leiomyomatosis and renal cell cancer: an unusual and aggressive form of hereditary renal carcinoma. Nat Clin Pract Oncol 4:256\u2013261","journal-title":"Nat Clin Pract Oncol"},{"key":"9735_CR21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5070\/D382P000CW","volume":"14","author":"H Ghaninejad","year":"2008","unstructured":"Ghaninejad H, Moeineddin F, Rajaee A et al (2008) Hereditary leiomyomatosis and renal cell carcinoma syndrome: a case report. Dermatol Online J 14:16","journal-title":"Dermatol Online J"},{"key":"9735_CR22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cancergencyto.2008.01.010","volume":"183","author":"T Ahvenainen","year":"2008","unstructured":"Ahvenainen T, Lehtonen HJ, Lehtonen R et al (2008) Mutation screening of fumarate hydratase by multiplex ligation-dependent probe amplification: detection of exonic deletion in a patient with leiomyomatosis and renal cell cancer. Cancer Genet Cytogenet 183:83\u201388","journal-title":"Cancer Genet Cytogenet"},{"key":"9735_CR23","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10689-009-9306-0","volume":"9","author":"I Alrashdi","year":"2010","unstructured":"Alrashdi I, Levine S, Paterson J et al (2010) Hereditary leiomyomatosis and renal cell carcinoma: very early diagnosis of renal cancer in a paediatric patient. Fam Cancer 9:239\u2013243","journal-title":"Fam Cancer"},{"key":"9735_CR24","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1159\/000321336","volume":"221","author":"F Rongioletti","year":"2010","unstructured":"Rongioletti F, Fausti V, Ferrando B et al (2010) A novel missense mutation in fumarate hydratase in an Italian patient with a diffuse variant of cutaneous leiomyomatosis (Reed\u2019s syndrome). Dermatology 221:378\u2013380","journal-title":"Dermatology"},{"key":"9735_CR25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0140-6736(09)61499-9","volume":"375","author":"M Onder","year":"2010","unstructured":"Onder M, Glenn G, Adisen E et al (2010) Cutaneous papules, uterine fibroids, and renal cell cancer: one family\u2019s tale. Lancet 375:170","journal-title":"Lancet"},{"key":"9735_CR26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrurol.2010.234","volume":"8","author":"T Yamasaki","year":"2011","unstructured":"Yamasaki T, Tran TAT, Oz OK et al (2011) Exploring a glycolytic inhibitor for the treatment of an FH-deficient type-2 papillary RCC. Nat Rev Urol 8:165\u2013171","journal-title":"Nat Rev Urol"},{"key":"9735_CR27","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10689-011-9485-3","volume":"11","author":"VM Raymond","year":"2012","unstructured":"Raymond VM, Herron CM, Giordano TJ et al (2012) Familial renal cancer as an indicator of hereditary leiomyomatosis and renal cell cancer syndrome. Fam Cancer 11:115\u2013121","journal-title":"Fam Cancer"},{"key":"9735_CR28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10689-011-9491-5","volume":"11","author":"KY Spaendonck-Zwarts Van","year":"2012","unstructured":"Van Spaendonck-Zwarts KY, Badeloe S, Oosting SF et al (2012) Hereditary leiomyomatosis and renal cell cancer presenting as metastatic kidney cancer at 18\u00a0years of age: implications for surveillance. Fam Cancer 11:123\u2013129","journal-title":"Fam Cancer"},{"key":"9735_CR29","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2490-13-3","volume":"13","author":"CL Behnes","year":"2013","unstructured":"Behnes CL, Schlegel C, Shoukier M et al (2013) Hereditary papillary renal cell carcinoma primarily diagnosed in a cervical lymph node: a case report of a 30-year-old woman with multiple metastases. BMC Urol 13:3","journal-title":"BMC Urol"},{"key":"9735_CR30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/1756-0500-7-203","volume":"7","author":"M Kuwada","year":"2014","unstructured":"Kuwada M, Chihara Y, Lou Y et al (2014) Novel missense mutation in the FH gene in familial renal cancer patients lacking cutaneous leiomyomas. BMC Res Notes 7:203","journal-title":"BMC Res Notes"},{"key":"9735_CR31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2350-9-20","volume":"9","author":"J-P Bayley","year":"2008","unstructured":"Bayley J-P, Launonen V, Tomlinson IPM (2008) The FH mutation database: an online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency. BMC Med Genet 9:20","journal-title":"BMC Med Genet"},{"key":"9735_CR32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10689-009-9312-2","volume":"9","author":"P Vahteristo","year":"2010","unstructured":"Vahteristo P, Koski TA, N\u00e4\u00e4tsaari L et al (2010) No evidence for a genetic modifier for renal cell cancer risk in HLRCC syndrome. Fam Cancer 9:245\u2013251","journal-title":"Fam Cancer"},{"key":"9735_CR33","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ucl.2012.01.005","volume":"39","author":"PA Kennedy","year":"2012","unstructured":"Kennedy PA (2012) Wood CG Integration of surgery and systemic therapy for renal cell carcinoma. Urol Clin N Am 39:211\u2013231","journal-title":"Urol Clin N Am"},{"key":"9735_CR34","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.eururo.2012.02.039","volume":"61","author":"S MacLennan","year":"2012","unstructured":"MacLennan S, Imamura M, Lapitan MC et al (2012) Systematic review of oncological outcomes following surgical management of localised renal cancer. Eur Urol 61:972\u2013993","journal-title":"Eur Urol"},{"key":"9735_CR35","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0022-5347(05)68930-6","volume":"161","author":"MM Walther","year":"1999","unstructured":"Walther MM, Choyke PL, Glenn G et al (1999) Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery. J Urol 161:1475\u20131479","journal-title":"J Urol"},{"key":"9735_CR36","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0022-5347(05)66524-X","volume":"165","author":"JC Herring","year":"2001","unstructured":"Herring JC, Enquist EG, Chernoff A et al (2001) Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience. J Urol 165:777\u2013781","journal-title":"J Urol"},{"key":"9735_CR37","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/01.ju.0000132127.79974.3f","volume":"172","author":"BG Duffey","year":"2004","unstructured":"Duffey BG, Choyke PL, Glenn G et al (2004) The relationship between renal tumor size and metastases in patients with von Hippel\u2013Lindau disease. J Urol 172:63\u201365","journal-title":"J Urol"},{"key":"9735_CR38","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/ncpuro0179","volume":"2","author":"RL Grubb III","year":"2005","unstructured":"Grubb RL III, Choyke PL, Pinto PA et al (2005) Management of von Hippel\u2013Lindau-associated kidney cancer. Nat Clin Pract Urol 2:248\u2013255","journal-title":"Nat Clin Pract Urol"},{"key":"9735_CR39","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1097\/01.ju.0000154629.45832.30","volume":"173","author":"CP Pavlovich","year":"2005","unstructured":"Pavlovich CP, Grubb RL III, Hurley K et al (2005) Evaluation and management of renal tumors in the Birt\u2013Hogg\u2013Dub\u00e9 syndrome. J Urol 173:1482\u20131486","journal-title":"J Urol"},{"key":"9735_CR40","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1016\/j.juro.2011.02.007","volume":"185","author":"D Joly","year":"2011","unstructured":"Joly D, M\u00e9jean A, Corr\u00e9as JM et al (2011) Progress in nephron sparing therapy for renal cell carcinoma and von Hippel\u2013Lindau disease. J Urol 185:2056\u20132060","journal-title":"J Urol"},{"key":"9735_CR41","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ucl.2012.02.002","volume":"39","author":"B Hu","year":"2012","unstructured":"Hu B, Lara PN Jr, Evans CP (2012) Defining an individualized treatment strategy for metastatic renal cancer. Urol Clin N Am 39:233\u2013249","journal-title":"Urol Clin N Am"},{"key":"9735_CR42","unstructured":"Ljungberg B, Bensalah K, Bex A et al (2013) Guidelines on renal cell carcinoma. Eur Assoc Urol. www.uroweb.org"},{"key":"9735_CR43","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nrurol.2010.47","volume":"7","author":"WM Linehan","year":"2010","unstructured":"Linehan WM, Srinivasan R, Schmidt LS (2010) The genetic basis of kidney cancer: a metabolic disease. Nat Rev Urol 7:277\u2013285","journal-title":"Nat Rev Urol"},{"key":"9735_CR44","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1101\/gr.131110.111","volume":"22","author":"WM Linehan","year":"2012","unstructured":"Linehan WM (2012) Genetic basis of kidney cancer: role of genomics for the development of disease-based therapeutics. Genome Res 22:2089\u20132100","journal-title":"Genome Res"},{"key":"9735_CR45","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nature10642","volume":"481","author":"AR Mullen","year":"2011","unstructured":"Mullen AR, Wheaton WW, Jin ES (2011) Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 481:385\u2013388","journal-title":"Nature"},{"key":"9735_CR46","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ccr.2011.07.018","volume":"20","author":"W-H Tong","year":"2011","unstructured":"Tong W-H, Sourbier C, Kovtunovych G et al (2011) The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels. Cancer Cell 20:315\u2013327","journal-title":"Cancer Cell"},{"key":"9735_CR47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ccr.2005.06.017","volume":"8","author":"JS Isaacs","year":"2005","unstructured":"Isaacs JS, Jung YJ, Mole DR et al (2005) HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8:143\u2013153","journal-title":"Cancer Cell"},{"key":"9735_CR48","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fonc.2012.00085","volume":"2","author":"M Yang","year":"2012","unstructured":"Yang M, Soga T, Pollard PJ et al (2012) The emerging role of fumarate as an oncometabolite. Front Oncol 2:85","journal-title":"Front Oncol"},{"key":"9735_CR49","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1101\/gad.191056.112","volume":"26","author":"M Xiao","year":"2012","unstructured":"Xiao M, Yang H, Xu W et al (2012) Inhibition of \u03b1-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev 26:1326\u20131338","journal-title":"Genes Dev"},{"key":"9735_CR50","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cell.2013.03.004","volume":"153","author":"WG Kaelin Jr","year":"2013","unstructured":"Kaelin WG Jr, McKnight SL (2013) Influence of metabolism on epigenetics and disease. Cell 153:56\u201369","journal-title":"Cell"},{"key":"9735_CR51","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/CCO.0b013e328351c646","volume":"24","author":"EA Singer","year":"2012","unstructured":"Singer EA, Gupta GN, Srinivasan R (2012) Targeted therapeutic strategies for the management of renal cell carcinoma. Curr Opin Oncol 24:284\u2013290","journal-title":"Curr Opin Oncol"},{"key":"9735_CR52","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1158\/1078-0432.CCR-13-0304","volume":"19","author":"WM Linehan","year":"2013","unstructured":"Linehan WM, Rouault TA (2013) Molecular pathways: fumarate hydratase-deficient kidney cancer\u2014targeting the Warburg effect in cancer. Clin Cancer Res 19:3345\u20133352","journal-title":"Clin Cancer Res"},{"key":"9735_CR53","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1001\/archdermatol.2008.517","volume":"144","author":"L Stewart","year":"2008","unstructured":"Stewart L, Glenn GM, Stratton P et al (2008) Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer. Arch Dermatol 144:1584\u20131592","journal-title":"Arch Dermatol"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-014-9735-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-014-9735-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-014-9735-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T23:47:10Z","timestamp":1689378430000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-014-9735-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,11]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["9735"],"URL":"https:\/\/doi.org\/10.1007\/s10689-014-9735-2","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,11]]}}}